HK1050143A1 - 5ht 2 agonists for controlling iop and treating glaucoma - Google Patents

5ht 2 agonists for controlling iop and treating glaucoma

Info

Publication number
HK1050143A1
HK1050143A1 HK03102379A HK03102379A HK1050143A1 HK 1050143 A1 HK1050143 A1 HK 1050143A1 HK 03102379 A HK03102379 A HK 03102379A HK 03102379 A HK03102379 A HK 03102379A HK 1050143 A1 HK1050143 A1 HK 1050143A1
Authority
HK
Hong Kong
Prior art keywords
agonists
treating glaucoma
controlling iop
iop
controlling
Prior art date
Application number
HK03102379A
Other languages
English (en)
Inventor
Jesse A May
Anura O Dantanarayana
Original Assignee
Alcon Inc
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc, Yamanouchi Pharma Co Ltd filed Critical Alcon Inc
Publication of HK1050143A1 publication Critical patent/HK1050143A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK03102379A 2000-03-17 2003-04-02 5ht 2 agonists for controlling iop and treating glaucoma HK1050143A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19028800P 2000-03-17 2000-03-17
PCT/US2000/031246 WO2001070207A2 (en) 2000-03-17 2000-11-14 5ht2 agonists for controlling iop and treating glaucoma

Publications (1)

Publication Number Publication Date
HK1050143A1 true HK1050143A1 (en) 2003-06-13

Family

ID=22700724

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03102379A HK1050143A1 (en) 2000-03-17 2003-04-02 5ht 2 agonists for controlling iop and treating glaucoma

Country Status (20)

Country Link
EP (1) EP1267847B1 (es)
JP (1) JP2003527415A (es)
KR (1) KR100499903B1 (es)
CN (1) CN1231214C (es)
AR (1) AR026707A1 (es)
AT (1) ATE258793T1 (es)
AU (2) AU2001216071B2 (es)
BR (1) BR0017158A (es)
CA (1) CA2401969A1 (es)
DE (1) DE60008151T2 (es)
DK (1) DK1267847T3 (es)
ES (1) ES2210018T3 (es)
HK (1) HK1050143A1 (es)
MX (1) MXPA02008548A (es)
PL (1) PL358296A1 (es)
PT (1) PT1267847E (es)
TR (1) TR200400424T4 (es)
TW (1) TW546139B (es)
WO (1) WO2001070207A2 (es)
ZA (1) ZA200206852B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6960579B1 (en) 1998-05-19 2005-11-01 Alcon Manufacturing, Ltd. Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders
TW593302B (en) 2001-12-20 2004-06-21 Alcon Inc Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma
BR0316775A (pt) 2002-12-13 2005-11-01 Alcon Inc Novos análogos de benzopirano e seu uso para o tratamento de glaucoma
WO2005053688A1 (en) * 2003-11-26 2005-06-16 Alcon, Inc. Substituted furo[2,3-g] indazoles for the treatment of glaucoma
US7129257B1 (en) 2003-12-15 2006-10-31 Alcon, Inc. Pyrazolo[3,4- e]benzoxazoles for the treatment of glaucoma
US7338972B1 (en) 2003-12-15 2008-03-04 Alcon, Inc. Substituted 1-alkylamino-1H-indazoles for the treatment of glaucoma
US6989445B2 (en) 2003-12-15 2006-01-24 Alcon, Inc. Substituted [1,4]oxazino[2,3-g]indazoles for the treatment of glaucoma
WO2006022420A1 (ja) 2004-08-25 2006-03-02 Takeda Pharmaceutical Company Limited 腹圧性尿失禁の予防・治療剤及びそのスクリーニング方法
US7425572B2 (en) 2004-12-08 2008-09-16 Alcon, Inc. Use of dioxindoindazoles and dioxoloindazoles for treating glaucoma
EP2742936A1 (en) 2006-05-16 2014-06-18 Takeda Pharmaceutical Company Limited Fused heterocyclic compound and use thereof
US20100266504A1 (en) 2007-11-15 2010-10-21 Takahiro Matsumoto Condensed pyridine derivative and use thereof
WO2011071136A1 (ja) 2009-12-11 2011-06-16 アステラス製薬株式会社 線維筋痛症治療剤
US20210052600A1 (en) 2017-12-27 2021-02-25 Takeda Pharmaceutical Company Limited Therapeutic agents for stress urinary incontinence and incotinence of feces

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3560986B2 (ja) * 1997-01-13 2004-09-02 山之内製薬株式会社 ５―ｈｔ２ｃ受容体作用薬及びアミノアルキルインダゾール誘導体
AU2042301A (en) * 1999-12-03 2001-06-12 Alcon Universal Limited 1-aminoalkyl-1H-indoles for treating glaucoma

Also Published As

Publication number Publication date
ZA200206852B (en) 2003-08-27
BR0017158A (pt) 2003-06-03
AU1607101A (en) 2001-10-03
MXPA02008548A (es) 2004-08-23
ES2210018T3 (es) 2004-07-01
CN1450897A (zh) 2003-10-22
TW546139B (en) 2003-08-11
DE60008151D1 (de) 2004-03-11
PT1267847E (pt) 2004-05-31
WO2001070207A2 (en) 2001-09-27
ATE258793T1 (de) 2004-02-15
CN1231214C (zh) 2005-12-14
DE60008151T2 (de) 2004-07-08
EP1267847A2 (en) 2003-01-02
AU2001216071B2 (en) 2004-12-02
EP1267847B1 (en) 2004-02-04
JP2003527415A (ja) 2003-09-16
WO2001070207A3 (en) 2002-05-10
KR20030095185A (ko) 2003-12-18
PL358296A1 (en) 2004-08-09
CA2401969A1 (en) 2001-09-27
DK1267847T3 (da) 2004-03-08
AR026707A1 (es) 2003-02-26
KR100499903B1 (ko) 2005-07-07
TR200400424T4 (tr) 2004-03-22

Similar Documents

Publication Publication Date Title
HK1038516A1 (en) Serotonergic 5ht2 agonists for treating glaucoma
AU5393400A (en) Device for treating glaucoma of the eye
AU2593900A (en) Composition and method for treating glaucoma
IL158775A0 (en) Use of an antioxidant for treating and or preventing surface ocular disorders
HK1050143A1 (en) 5ht 2 agonists for controlling iop and treating glaucoma
HUP0402113A3 (en) 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity, preparation and use thereof
EP1414464A4 (en) METHOD OF TREATING GLAUCOMA
WO2000038663A3 (en) Ep4 receptor agonists for treatment of dry eye
EP1461076A4 (en) METHODS AND COMPOSITIONS FOR TREATING LESIONS OF RESPIRATORY EPITHELIUM
GC0000155A (en) 6-Hydroxy-indazole derivatives for treating glaucoma.
AU2042301A (en) 1-aminoalkyl-1H-indoles for treating glaucoma
HK1040184A1 (zh) 治療青光眼之組合療法
EP1267903A4 (en) METHODS OF TREATING GLAUCOMA
MXPA03003741A (es) Metodos y composiciones para el tratamiento de enfermedades oftalmicas.
EP1383529A4 (en) METHOD FOR THE TREATMENT OF EYES AND SQUATING TISSUES WITH THYMOSINE 4 (T 4), ANALOGUE, ISOFORMS AND OTHER DERIVATIVES
AU6661901A (en) Naaladase inhibitors for treating retinal disorders and glaucoma
EP1455780A4 (en) NEW BENZODIFURANIMIDAZOLIN AND BENZOFURANIMIDAZOLIN DERIVATIVES AND THEIR USE FOR THE TREATMENT OF GLAUCOMA
AU1603401A (en) Pyranoindoles for treating glaucoma
AU2002215187A1 (en) S-adenosylmethionine and derivatives thereof for the treatment and prevention ofalzheimer's disease
HK1066211A1 (en) Benzo (g) quinoline derivatives for treating glaucoma and myopia
AU2001289735A1 (en) Chromenone derivatives and their use for treating diseases in conjunction with 5-HTA 1 receptors and/or dopamine D2 receptors
PL341707A1 (en) Compounds exibiting growth hormone releasing properties
IL151683A0 (en) Composition for use in treatment of ocular hypertension and glaucoma
ZA200302911B (en) Method and composition for treatment of ocular hypertension and glaucoma.
AU7799898A (en) Compositions and methods for treating glaucoma

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20071114